Gene Symbol | Gene ID | Gene Info |
---|---|---|
Meis1
|
ENSMUSG00000020160.12 | Meis homeobox 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_19020308_19020867 | Meis1 | 1602 | 0.298938 | 0.61 | 7.4e-07 | Click! |
chr11_19020966_19021170 | Meis1 | 2083 | 0.241059 | 0.57 | 5.4e-06 | Click! |
chr11_19019600_19020162 | Meis1 | 896 | 0.499432 | 0.55 | 1.4e-05 | Click! |
chr11_19026616_19026803 | Meis1 | 7724 | 0.145278 | 0.47 | 2.8e-04 | Click! |
chr11_19026900_19027097 | Meis1 | 8013 | 0.144605 | 0.44 | 8.3e-04 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr17_65961618_65962124 | 49.70 |
Ankrd12 |
ankyrin repeat domain 12 |
10521 |
0.14 |
chr1_151801648_151802002 | 17.08 |
Edem3 |
ER degradation enhancer, mannosidase alpha-like 3 |
46365 |
0.12 |
chrY_90739614_90740540 | 12.98 |
Mid1-ps1 |
midline 1, pseudogene 1 |
12980 |
0.18 |
chr5_90033144_90033504 | 10.38 |
Eif5al3-ps |
eukaryotic translation initiation factor 5A-like 3, pseudogene |
98905 |
0.08 |
chr3_82406341_82406796 | 9.16 |
Map9 |
microtubule-associated protein 9 |
26495 |
0.24 |
chr19_28453023_28453301 | 8.55 |
Glis3 |
GLIS family zinc finger 3 |
87258 |
0.09 |
chr1_89550370_89550583 | 8.26 |
Gm25180 |
predicted gene, 25180 |
12884 |
0.18 |
chr1_151802325_151802541 | 7.88 |
Edem3 |
ER degradation enhancer, mannosidase alpha-like 3 |
46973 |
0.12 |
chr4_23913542_23913728 | 7.56 |
Gm28448 |
predicted gene 28448 |
20319 |
0.29 |
chr8_90535848_90536064 | 7.34 |
Gm45639 |
predicted gene 45639 |
139002 |
0.04 |
chr14_123065358_123065532 | 7.31 |
AA536875 |
expressed sequence AA536875 |
22163 |
0.22 |
chr9_103504895_103505451 | 6.99 |
Tmem108 |
transmembrane protein 108 |
11562 |
0.11 |
chr17_13654565_13655321 | 6.94 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
13948 |
0.15 |
chr13_93073637_93073972 | 6.55 |
Gm4814 |
predicted gene 4814 |
425 |
0.85 |
chr8_9124477_9125000 | 6.49 |
4933430N04Rik |
RIKEN cDNA 4933430N04 gene |
7550 |
0.18 |
chr7_51748719_51749329 | 6.39 |
Gm7336 |
predicted gene 7336 |
2377 |
0.28 |
chr4_5962683_5962879 | 6.33 |
Gm11797 |
predicted gene 11797 |
107093 |
0.07 |
chr4_41612407_41612596 | 6.23 |
Dnaic1 |
dynein, axonemal, intermediate chain 1 |
19143 |
0.1 |
chr10_13107920_13108404 | 6.19 |
Plagl1 |
pleiomorphic adenoma gene-like 1 |
5303 |
0.23 |
chr1_151801329_151801530 | 6.11 |
Edem3 |
ER degradation enhancer, mannosidase alpha-like 3 |
45969 |
0.12 |
chr2_49620647_49620914 | 6.09 |
Kif5c |
kinesin family member 5C |
1482 |
0.5 |
chr4_97236512_97236673 | 6.07 |
Gm12696 |
predicted gene 12696 |
285740 |
0.01 |
chr6_32373945_32374204 | 6.05 |
Plxna4os3 |
plexin A4, opposite strand 3 |
70161 |
0.11 |
chr9_36881381_36881946 | 6.04 |
Fez1 |
fasciculation and elongation protein zeta 1 (zygin I) |
11160 |
0.19 |
chr5_35918677_35918991 | 5.99 |
H2af-ps |
H2A histone family, pseudogene |
937 |
0.6 |
chr8_70118830_70119054 | 5.97 |
Ncan |
neurocan |
1931 |
0.15 |
chr2_14535212_14535413 | 5.94 |
Gm13266 |
predicted gene 13266 |
22713 |
0.16 |
chr6_114289060_114289436 | 5.93 |
Slc6a1 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 1 |
6458 |
0.27 |
chr17_48999548_48999943 | 5.63 |
Lrfn2 |
leucine rich repeat and fibronectin type III domain containing 2 |
67366 |
0.11 |
chr16_33605736_33606716 | 5.62 |
Slc12a8 |
solute carrier family 12 (potassium/chloride transporters), member 8 |
9599 |
0.26 |
chr7_133190005_133190156 | 5.60 |
4930483O08Rik |
RIKEN cDNA 4930483O08 gene |
61829 |
0.1 |
chr3_137057221_137057402 | 5.53 |
Gm26107 |
predicted gene, 26107 |
10581 |
0.26 |
chr7_112779926_112780077 | 5.50 |
Tead1 |
TEA domain family member 1 |
20455 |
0.21 |
chr18_37218144_37218452 | 5.49 |
Gm10544 |
predicted gene 10544 |
39776 |
0.08 |
chr6_36777083_36777501 | 5.47 |
Ptn |
pleiotrophin |
32887 |
0.2 |
chr11_25854231_25854525 | 5.43 |
5730522E02Rik |
RIKEN cDNA 5730522E02 gene |
85237 |
0.11 |
chr1_151802005_151802215 | 5.40 |
Edem3 |
ER degradation enhancer, mannosidase alpha-like 3 |
46650 |
0.12 |
chr12_25871193_25871842 | 5.33 |
Gm47733 |
predicted gene, 47733 |
364 |
0.91 |
chr18_33447562_33447713 | 5.31 |
Nrep |
neuronal regeneration related protein |
15798 |
0.2 |
chr13_59041258_59041434 | 5.29 |
Gm34245 |
predicted gene, 34245 |
36950 |
0.14 |
chr3_39838579_39838758 | 5.29 |
Gm42785 |
predicted gene 42785 |
15091 |
0.2 |
chr6_96286333_96286534 | 5.27 |
1700123L14Rik |
RIKEN cDNA 1700123L14 gene |
120190 |
0.06 |
chr14_62416217_62416427 | 5.25 |
Gucy1b2 |
guanylate cyclase 1, soluble, beta 2 |
38471 |
0.13 |
chr2_65668417_65668738 | 5.19 |
Scn2a |
sodium channel, voltage-gated, type II, alpha |
109 |
0.98 |
chr18_49117752_49118229 | 5.15 |
Gm18993 |
predicted gene, 18993 |
54566 |
0.18 |
chr7_6727792_6729098 | 5.13 |
Peg3 |
paternally expressed 3 |
1974 |
0.16 |
chr6_36931501_36931832 | 5.13 |
1700111E14Rik |
RIKEN cDNA 1700111E14 gene |
5382 |
0.26 |
chr18_57259582_57259777 | 5.11 |
Gm50200 |
predicted gene, 50200 |
55461 |
0.11 |
chr4_138504549_138504859 | 5.11 |
Camk2n1 |
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
50390 |
0.1 |
chr3_30452791_30452942 | 5.10 |
Gm37024 |
predicted gene, 37024 |
35560 |
0.14 |
chr2_158846450_158846601 | 5.10 |
Dhx35 |
DEAH (Asp-Glu-Ala-His) box polypeptide 35 |
4104 |
0.28 |
chr12_17070029_17070206 | 5.07 |
Gm48538 |
predicted gene, 48538 |
4704 |
0.23 |
chr10_43625591_43625924 | 5.04 |
F930017D23Rik |
RIKEN cDNA F930017D23 gene |
2010 |
0.24 |
chr11_45191472_45191662 | 5.03 |
Gm38087 |
predicted gene, 38087 |
1695 |
0.41 |
chr2_137939077_137939470 | 5.01 |
Gm14062 |
predicted gene 14062 |
62442 |
0.16 |
chr16_63806441_63806811 | 4.99 |
Epha3 |
Eph receptor A3 |
56787 |
0.15 |
chr5_70501492_70501643 | 4.93 |
Gm26072 |
predicted gene, 26072 |
49380 |
0.15 |
chr2_38348352_38348831 | 4.82 |
Gm27197 |
predicted gene 27197 |
275 |
0.87 |
chr12_44338422_44338729 | 4.81 |
Nrcam |
neuronal cell adhesion molecule |
9325 |
0.18 |
chr13_97253425_97254036 | 4.79 |
Enc1 |
ectodermal-neural cortex 1 |
12625 |
0.16 |
chr10_90576386_90576809 | 4.78 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
15 |
0.99 |
chr4_85256505_85256861 | 4.78 |
Gm12413 |
predicted gene 12413 |
10921 |
0.25 |
chr8_23596316_23596734 | 4.72 |
Zmat4 |
zinc finger, matrin type 4 |
39494 |
0.19 |
chr16_76866459_76866678 | 4.71 |
1700041M19Rik |
RIKEN cDNA 1700041M19 gene |
22713 |
0.18 |
chr12_98572342_98572496 | 4.71 |
Kcnk10 |
potassium channel, subfamily K, member 10 |
2293 |
0.23 |
chr18_45014470_45014883 | 4.67 |
Gm31706 |
predicted gene, 31706 |
30186 |
0.16 |
chr3_68072068_68072422 | 4.66 |
Schip1 |
schwannomin interacting protein 1 |
7443 |
0.3 |
chr16_95597559_95597761 | 4.64 |
Erg |
ETS transcription factor |
11067 |
0.26 |
chr16_36817082_36817234 | 4.62 |
Eaf2 |
ELL associated factor 2 |
8453 |
0.11 |
chr1_118913010_118913408 | 4.61 |
Mir6346 |
microRNA 6346 |
41011 |
0.16 |
chr9_26623120_26623320 | 4.58 |
Gm30313 |
predicted gene, 30313 |
73267 |
0.1 |
chr3_145890165_145890867 | 4.57 |
Rpl36a-ps2 |
ribosomal protein L36A, pseudogene 2 |
11496 |
0.18 |
chr6_40023721_40024003 | 4.56 |
Gm37995 |
predicted gene, 37995 |
3032 |
0.29 |
chr10_90576927_90577174 | 4.55 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
58 |
0.99 |
chr14_66494473_66494955 | 4.55 |
Gm23899 |
predicted gene, 23899 |
96981 |
0.07 |
chr15_10655238_10655729 | 4.53 |
Gm10389 |
predicted gene 10389 |
55146 |
0.1 |
chr1_132292340_132292811 | 4.52 |
Klhdc8a |
kelch domain containing 8A |
6051 |
0.12 |
chr5_42777840_42778008 | 4.51 |
Gm5554 |
predicted gene 5554 |
186685 |
0.03 |
chr11_3132475_3133419 | 4.51 |
Sfi1 |
Sfi1 homolog, spindle assembly associated (yeast) |
3060 |
0.17 |
chr16_44538220_44538681 | 4.51 |
Mir3081 |
microRNA 3081 |
19679 |
0.18 |
chr19_14518544_14518881 | 4.49 |
Tle4 |
transducin-like enhancer of split 4 |
76827 |
0.11 |
chr5_132034084_132034283 | 4.48 |
Auts2 |
autism susceptibility candidate 2 |
5557 |
0.15 |
chr12_102640402_102640771 | 4.48 |
Itpk1 |
inositol 1,3,4-triphosphate 5/6 kinase |
348 |
0.83 |
chr18_37217890_37218056 | 4.46 |
Gm10544 |
predicted gene 10544 |
39451 |
0.08 |
chr18_84232190_84232510 | 4.43 |
Gm50311 |
predicted gene, 50311 |
29426 |
0.2 |
chrX_42361720_42361910 | 4.42 |
Gm14619 |
predicted gene 14619 |
14303 |
0.27 |
chr17_90088341_90088533 | 4.40 |
Nrxn1 |
neurexin I |
37 |
0.99 |
chr4_49041678_49042070 | 4.37 |
Plppr1 |
phospholipid phosphatase related 1 |
17399 |
0.23 |
chr9_98525635_98525807 | 4.36 |
Gm37113 |
predicted gene, 37113 |
31753 |
0.11 |
chr4_12775191_12775388 | 4.35 |
n-R5s182 |
nuclear encoded rRNA 5S 182 |
37417 |
0.22 |
chr4_81124388_81124544 | 4.34 |
Gm27452 |
predicted gene, 27452 |
157022 |
0.04 |
chr7_69217998_69218568 | 4.34 |
Gm5342 |
predicted gene 5342 |
8399 |
0.26 |
chr6_61492448_61492759 | 4.33 |
Ccser1 |
coiled-coil serine rich 1 |
78067 |
0.11 |
chr15_94803844_94804006 | 4.32 |
Gm25546 |
predicted gene, 25546 |
122539 |
0.06 |
chr13_84566286_84566489 | 4.31 |
Gm26913 |
predicted gene, 26913 |
124554 |
0.06 |
chr1_190334220_190334375 | 4.31 |
Gm29678 |
predicted gene, 29678 |
69348 |
0.11 |
chr1_9300669_9300959 | 4.30 |
Sntg1 |
syntrophin, gamma 1 |
936 |
0.56 |
chr19_28381956_28382324 | 4.29 |
Glis3 |
GLIS family zinc finger 3 |
56134 |
0.16 |
chr10_61517718_61517959 | 4.29 |
Gm17829 |
predicted gene, 17829 |
7253 |
0.12 |
chrX_134686235_134686690 | 4.29 |
B230119M05Rik |
RIKEN cDNA B230119M05 gene |
0 |
0.52 |
chr12_90915906_90916594 | 4.28 |
Gm47688 |
predicted gene, 47688 |
22132 |
0.17 |
chr7_64533404_64533751 | 4.27 |
Gm44721 |
predicted gene 44721 |
4152 |
0.22 |
chr8_64644300_64644451 | 4.27 |
Cpe |
carboxypeptidase E |
22378 |
0.19 |
chr11_105508467_105508712 | 4.25 |
Marchf10 |
membrane associated ring-CH-type finger 10 |
51854 |
0.12 |
chr5_14054551_14054702 | 4.23 |
Gm4128 |
predicted gene 4128 |
19531 |
0.17 |
chr7_96168957_96169147 | 4.22 |
Tenm4 |
teneurin transmembrane protein 4 |
2194 |
0.37 |
chrX_79517025_79517192 | 4.22 |
Cfap47 |
cilia and flagella associated protein 47 |
177 |
0.97 |
chr13_89797795_89798023 | 4.21 |
Vcan |
versican |
55400 |
0.13 |
chr16_44552477_44552628 | 4.21 |
Mir3081 |
microRNA 3081 |
5577 |
0.22 |
chr1_18307976_18308135 | 4.21 |
Defb41 |
defensin beta 41 |
42917 |
0.14 |
chr17_3275020_3275269 | 4.20 |
Gm34035 |
predicted gene, 34035 |
8063 |
0.17 |
chr1_151802571_151802722 | 4.19 |
Edem3 |
ER degradation enhancer, mannosidase alpha-like 3 |
47186 |
0.12 |
chr18_45897557_45897714 | 4.19 |
A330093E20Rik |
RIKEN cDNA A330093E20 gene |
1126 |
0.6 |
chr3_50044774_50044968 | 4.19 |
Gm37826 |
predicted gene, 37826 |
15202 |
0.23 |
chr13_34131726_34132056 | 4.17 |
Tubb2b |
tubulin, beta 2B class IIB |
1425 |
0.24 |
chr11_24740164_24740317 | 4.17 |
Gm10466 |
predicted gene 10466 |
9518 |
0.27 |
chr13_35980456_35980789 | 4.16 |
Tmed10-ps |
transmembrane p24 trafficking protein 10, pseudogene |
10898 |
0.11 |
chr1_94502083_94502408 | 4.15 |
Gm7895 |
predicted gene 7895 |
32358 |
0.23 |
chr9_100558108_100558271 | 4.15 |
Slc35g2 |
solute carrier family 35, member G2 |
5274 |
0.15 |
chr3_63583085_63583255 | 4.12 |
Gm24946 |
predicted gene, 24946 |
94177 |
0.07 |
chr17_3442694_3442901 | 4.11 |
Tiam2 |
T cell lymphoma invasion and metastasis 2 |
3024 |
0.26 |
chr9_118319094_118319336 | 4.09 |
2610509F24Rik |
RIKEN cDNA 2610509F24 gene |
84087 |
0.08 |
chr16_50732699_50733248 | 4.09 |
Dubr |
Dppa2 upstream binding RNA |
200 |
0.94 |
chr10_92438739_92438890 | 4.07 |
4930401A07Rik |
RIKEN cDNA 4930401A07 gene |
37800 |
0.13 |
chr13_84905442_84905636 | 4.06 |
Gm4059 |
predicted gene 4059 |
68778 |
0.12 |
chr3_139885937_139886924 | 4.06 |
Gm43678 |
predicted gene 43678 |
73666 |
0.11 |
chr2_116201357_116201527 | 4.06 |
2810405F15Rik |
RIKEN cDNA 2810405F15 gene |
125346 |
0.05 |
chr11_36074096_36074467 | 4.04 |
Gm12126 |
predicted gene 12126 |
6383 |
0.28 |
chr18_16037927_16038695 | 4.04 |
Gm4835 |
predicted pseudogene 4835 |
49943 |
0.17 |
chr4_62613321_62613879 | 4.03 |
Rgs3 |
regulator of G-protein signaling 3 |
5920 |
0.18 |
chr1_10596534_10596685 | 4.03 |
Gm25253 |
predicted gene, 25253 |
40949 |
0.15 |
chr1_106690804_106691150 | 4.02 |
Bcl2 |
B cell leukemia/lymphoma 2 |
22202 |
0.19 |
chr7_31127074_31128340 | 4.02 |
Scn1b |
sodium channel, voltage-gated, type I, beta |
704 |
0.47 |
chr2_170902623_170902819 | 4.01 |
Gm14263 |
predicted gene 14263 |
52103 |
0.17 |
chr3_136456846_136457013 | 4.00 |
1700030L20Rik |
RIKEN cDNA 1700030L20 gene |
7580 |
0.28 |
chr7_53109424_53109575 | 4.00 |
Gm22444 |
predicted gene, 22444 |
182429 |
0.03 |
chr3_98940920_98941331 | 3.99 |
5730437C11Rik |
RIKEN cDNA 5730437C11 gene |
131 |
0.96 |
chr6_134207480_134208194 | 3.97 |
Etv6 |
ets variant 6 |
25763 |
0.14 |
chr3_70873692_70873885 | 3.97 |
Gm10780 |
predicted gene 10780 |
184696 |
0.03 |
chr9_27454354_27454543 | 3.96 |
Spata19 |
spermatogenesis associated 19 |
56923 |
0.12 |
chr9_33822632_33822817 | 3.96 |
Gm47784 |
predicted gene, 47784 |
38479 |
0.16 |
chr4_62612568_62612795 | 3.96 |
Rgs3 |
regulator of G-protein signaling 3 |
6839 |
0.18 |
chr3_82137968_82138352 | 3.96 |
Gucy1a1 |
guanylate cyclase 1, soluble, alpha 1 |
6913 |
0.23 |
chr19_6976181_6976733 | 3.95 |
Ppp1r14b |
protein phosphatase 1, regulatory inhibitor subunit 14B |
8 |
0.48 |
chr1_78761027_78761232 | 3.94 |
Gm6159 |
predicted gene 6159 |
23730 |
0.17 |
chr17_48999972_49000154 | 3.94 |
Lrfn2 |
leucine rich repeat and fibronectin type III domain containing 2 |
67684 |
0.11 |
chr4_97910237_97910414 | 3.93 |
Nfia |
nuclear factor I/A |
708 |
0.8 |
chr2_38424519_38425045 | 3.93 |
Gm13589 |
predicted gene 13589 |
780 |
0.59 |
chr1_186506682_186506851 | 3.93 |
A730004F24Rik |
RIKEN cDNA A730004F24 gene |
51706 |
0.15 |
chr10_89487161_89487312 | 3.93 |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
19413 |
0.2 |
chr8_72646405_72646797 | 3.92 |
Nwd1 |
NACHT and WD repeat domain containing 1 |
110 |
0.96 |
chr3_9705413_9705575 | 3.91 |
Pag1 |
phosphoprotein associated with glycosphingolipid microdomains 1 |
492 |
0.83 |
chr5_5135037_5135401 | 3.90 |
Gm43623 |
predicted gene 43623 |
4888 |
0.21 |
chr15_57698095_57698247 | 3.89 |
Zhx2 |
zinc fingers and homeoboxes 2 |
2442 |
0.3 |
chr19_17180653_17180804 | 3.88 |
Prune2 |
prune homolog 2 |
27523 |
0.19 |
chr13_114603735_114603886 | 3.88 |
4930467J12Rik |
RIKEN cDNA 4930467J12 gene |
3274 |
0.22 |
chr14_96519046_96519225 | 3.88 |
Klhl1 |
kelch-like 1 |
33 |
0.98 |
chr10_112572699_112572878 | 3.88 |
Kcnc2 |
potassium voltage gated channel, Shaw-related subfamily, member 2 |
116445 |
0.06 |
chr1_151900848_151901028 | 3.88 |
1700025G04Rik |
RIKEN cDNA 1700025G04 gene |
20289 |
0.18 |
chr15_50997219_50997761 | 3.88 |
Gm48913 |
predicted gene, 48913 |
99851 |
0.08 |
chr18_60925808_60926037 | 3.87 |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
197 |
0.92 |
chr2_94289718_94289925 | 3.86 |
Mir670hg |
MIR670 host gene (non-protein coding) |
24903 |
0.13 |
chr13_92736952_92737361 | 3.85 |
Gm5199 |
predicted gene 5199 |
17794 |
0.18 |
chr18_23037418_23037876 | 3.85 |
Nol4 |
nucleolar protein 4 |
1009 |
0.7 |
chr8_26526511_26526817 | 3.85 |
Gm31983 |
predicted gene, 31983 |
42012 |
0.12 |
chr4_39344371_39344735 | 3.85 |
Gm23607 |
predicted gene, 23607 |
49090 |
0.15 |
chr2_116055796_116055957 | 3.85 |
Meis2 |
Meis homeobox 2 |
2966 |
0.23 |
chr2_43208323_43208495 | 3.84 |
Gm13464 |
predicted gene 13464 |
310989 |
0.01 |
chr19_22138901_22139141 | 3.83 |
Trpm3 |
transient receptor potential cation channel, subfamily M, member 3 |
25 |
0.99 |
chr18_37217169_37217576 | 3.83 |
Gm10544 |
predicted gene 10544 |
38850 |
0.08 |
chr19_51059955_51060162 | 3.83 |
Gm50317 |
predicted gene, 50317 |
84691 |
0.11 |
chr10_8517903_8518135 | 3.82 |
Ust |
uronyl-2-sulfotransferase |
806 |
0.76 |
chr1_151800543_151800694 | 3.82 |
Edem3 |
ER degradation enhancer, mannosidase alpha-like 3 |
45158 |
0.12 |
chr18_8871026_8871236 | 3.82 |
Gm37148 |
predicted gene, 37148 |
57104 |
0.14 |
chr3_126810807_126810958 | 3.81 |
Camk2d |
calcium/calmodulin-dependent protein kinase II, delta |
3720 |
0.24 |
chr13_42709847_42710338 | 3.81 |
Phactr1 |
phosphatase and actin regulator 1 |
511 |
0.85 |
chr7_63668498_63668747 | 3.81 |
Otud7a |
OTU domain containing 7A |
17807 |
0.2 |
chr1_132591364_132591989 | 3.80 |
Nfasc |
neurofascin |
4536 |
0.23 |
chr2_22029338_22029851 | 3.80 |
Gm13337 |
predicted gene 13337 |
38232 |
0.22 |
chr10_56059015_56059173 | 3.80 |
Gm29794 |
predicted gene, 29794 |
42909 |
0.17 |
chr16_91105228_91105413 | 3.79 |
H3f3a-ps2 |
H3.3 histone A, pseudogene 2 |
9279 |
0.11 |
chr4_4948953_4949104 | 3.79 |
Gm11779 |
predicted gene 11779 |
29846 |
0.25 |
chr1_151800263_151800422 | 3.78 |
Edem3 |
ER degradation enhancer, mannosidase alpha-like 3 |
44882 |
0.12 |
chr1_169747607_169747817 | 3.77 |
Rgs4 |
regulator of G-protein signaling 4 |
70 |
0.98 |
chr3_69494373_69494539 | 3.76 |
Ppm1l |
protein phosphatase 1 (formerly 2C)-like |
2757 |
0.3 |
chr1_57875514_57875995 | 3.76 |
Spats2l |
spermatogenesis associated, serine-rich 2-like |
26317 |
0.18 |
chr14_64233595_64233767 | 3.76 |
9630015K15Rik |
RIKEN cDNA 9630015K15 gene |
117367 |
0.05 |
chr16_96279105_96279256 | 3.75 |
B3galt5 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 |
1618 |
0.39 |
chr18_84368955_84369471 | 3.74 |
Gm37216 |
predicted gene, 37216 |
6933 |
0.26 |
chr3_137785224_137785392 | 3.73 |
Mir6380 |
microRNA 6380 |
1693 |
0.29 |
chr13_83884765_83885152 | 3.73 |
2810049E08Rik |
RIKEN cDNA 2810049E08 gene |
6250 |
0.23 |
chr18_83523941_83524284 | 3.73 |
Gm50416 |
predicted gene, 50416 |
1192 |
0.46 |
chr18_25662096_25662298 | 3.73 |
0710001A04Rik |
RIKEN cDNA 0710001A04 gene |
51573 |
0.15 |
chr5_97537996_97538189 | 3.72 |
Gk2 |
glycerol kinase 2 |
81071 |
0.1 |
chr10_25678013_25678179 | 3.72 |
Gm36543 |
predicted gene, 36543 |
29847 |
0.16 |
chr1_81593373_81593581 | 3.72 |
Gm6198 |
predicted gene 6198 |
35994 |
0.2 |
chr12_27838407_27838750 | 3.72 |
Gm45941 |
predicted gene, 45941 |
107464 |
0.07 |
chr13_78200366_78200817 | 3.72 |
A830082K12Rik |
RIKEN cDNA A830082K12 gene |
813 |
0.37 |
chr2_82053234_82053891 | 3.72 |
Zfp804a |
zinc finger protein 804A |
340 |
0.93 |
chr11_25157164_25157349 | 3.71 |
4933427E13Rik |
RIKEN cDNA 4933427E13 gene |
75370 |
0.11 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 7.4 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
2.4 | 7.1 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
2.4 | 7.1 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.8 | 7.1 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
1.6 | 19.4 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.6 | 11.0 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
1.5 | 5.8 | GO:0036508 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
1.3 | 10.0 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
1.3 | 3.8 | GO:0046684 | response to pyrethroid(GO:0046684) |
1.1 | 3.3 | GO:0071873 | response to norepinephrine(GO:0071873) |
1.1 | 3.2 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
1.0 | 3.1 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.0 | 2.1 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
1.0 | 3.1 | GO:0006808 | regulation of nitrogen utilization(GO:0006808) |
1.0 | 3.0 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
1.0 | 1.0 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.9 | 2.8 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.9 | 3.7 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.9 | 2.7 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.9 | 1.8 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.9 | 1.7 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.9 | 6.8 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.8 | 2.5 | GO:0035106 | operant conditioning(GO:0035106) |
0.8 | 2.5 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.8 | 2.5 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.8 | 2.4 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.8 | 3.1 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.8 | 3.1 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.8 | 2.3 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.7 | 1.5 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.7 | 2.2 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.7 | 2.2 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.7 | 2.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.7 | 1.4 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.7 | 2.1 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.7 | 2.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.7 | 0.7 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.7 | 2.1 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.7 | 0.7 | GO:0090135 | actin filament branching(GO:0090135) |
0.7 | 2.7 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.7 | 2.0 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.7 | 2.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.7 | 5.9 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
0.7 | 2.6 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.7 | 3.3 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.6 | 0.6 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.6 | 1.3 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.6 | 3.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.6 | 1.9 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.6 | 2.5 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.6 | 1.2 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.6 | 3.7 | GO:0031223 | auditory behavior(GO:0031223) |
0.6 | 3.7 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.6 | 2.4 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.6 | 1.2 | GO:0048880 | sensory system development(GO:0048880) |
0.6 | 1.2 | GO:0021564 | vagus nerve development(GO:0021564) |
0.6 | 4.7 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.6 | 1.7 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.6 | 1.7 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.6 | 1.7 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.6 | 1.7 | GO:0060437 | lung growth(GO:0060437) |
0.6 | 1.7 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.6 | 1.7 | GO:0046959 | habituation(GO:0046959) |
0.5 | 3.3 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.5 | 1.6 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.5 | 3.7 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.5 | 4.3 | GO:0060872 | semicircular canal development(GO:0060872) |
0.5 | 2.1 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.5 | 4.2 | GO:0050957 | equilibrioception(GO:0050957) |
0.5 | 1.6 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.5 | 2.1 | GO:0061743 | motor learning(GO:0061743) |
0.5 | 1.5 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.5 | 4.1 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.5 | 3.0 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.5 | 2.0 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.5 | 1.5 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.5 | 2.0 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.5 | 1.0 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.5 | 1.4 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.5 | 1.9 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.5 | 1.4 | GO:0097503 | sialylation(GO:0097503) |
0.5 | 1.4 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.5 | 0.5 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.5 | 0.5 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.4 | 1.3 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.4 | 3.1 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.4 | 3.1 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.4 | 3.5 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.4 | 0.4 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.4 | 1.7 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.4 | 0.9 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.4 | 1.7 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.4 | 2.5 | GO:0071625 | vocalization behavior(GO:0071625) |
0.4 | 1.7 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
0.4 | 1.2 | GO:0035696 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
0.4 | 1.7 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.4 | 1.2 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.4 | 0.8 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.4 | 1.2 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.4 | 1.2 | GO:0048840 | otolith development(GO:0048840) |
0.4 | 1.6 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.4 | 0.8 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.4 | 1.2 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.4 | 1.1 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.4 | 5.3 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.4 | 0.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.4 | 0.7 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.4 | 4.8 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.4 | 1.5 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.4 | 1.1 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.4 | 0.7 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.4 | 1.1 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.4 | 1.4 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.4 | 0.7 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.4 | 1.1 | GO:0046881 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.3 | 1.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.3 | 1.4 | GO:0022038 | corpus callosum development(GO:0022038) |
0.3 | 2.1 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.3 | 5.1 | GO:0060074 | synapse maturation(GO:0060074) |
0.3 | 1.7 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.3 | 1.0 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.3 | 4.1 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.3 | 1.0 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
0.3 | 2.7 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.3 | 1.0 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.3 | 5.3 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.3 | 1.0 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.3 | 1.3 | GO:0003383 | apical constriction(GO:0003383) |
0.3 | 3.6 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.3 | 1.3 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.3 | 1.0 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.3 | 1.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.3 | 2.6 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.3 | 0.3 | GO:0002339 | B cell selection(GO:0002339) |
0.3 | 1.0 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.3 | 0.6 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.3 | 1.0 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.3 | 2.6 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.3 | 1.0 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.3 | 0.6 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.3 | 1.0 | GO:0042628 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
0.3 | 1.3 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.3 | 0.9 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.3 | 1.2 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.3 | 1.2 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.3 | 0.6 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.3 | 1.5 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
0.3 | 0.6 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.3 | 0.3 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.3 | 0.9 | GO:0042891 | antibiotic transport(GO:0042891) |
0.3 | 0.9 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.3 | 0.9 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.3 | 0.6 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.3 | 1.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.3 | 0.9 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.3 | 0.6 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.3 | 1.2 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.3 | 0.9 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.3 | 0.9 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.3 | 0.6 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.3 | 0.9 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.3 | 0.6 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.3 | 0.9 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.3 | 0.9 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.3 | 0.6 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.3 | 0.3 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.3 | 0.6 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.3 | 2.3 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.3 | 0.8 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
0.3 | 0.6 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.3 | 0.6 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.3 | 0.6 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.3 | 1.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.3 | 1.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.3 | 0.8 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.3 | 0.8 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.3 | 2.7 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.3 | 0.3 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.3 | 0.8 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.3 | 1.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.3 | 3.2 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.3 | 1.3 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.3 | 0.3 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.3 | 1.8 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.3 | 0.5 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.3 | 1.3 | GO:0015808 | L-alanine transport(GO:0015808) |
0.3 | 0.8 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.3 | 1.3 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 0.5 | GO:0048664 | neuron fate determination(GO:0048664) |
0.2 | 1.0 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 1.0 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.2 | 0.7 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.2 | 0.7 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.2 | 1.5 | GO:0035989 | tendon development(GO:0035989) |
0.2 | 1.0 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.2 | 0.2 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.2 | 0.5 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.2 | 0.5 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.2 | 3.7 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
0.2 | 1.2 | GO:0060179 | male mating behavior(GO:0060179) |
0.2 | 1.4 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.2 | 0.2 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.2 | 0.5 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.2 | 0.9 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.2 | 0.5 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.2 | 0.9 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.2 | 0.9 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 0.4 | GO:0045963 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
0.2 | 0.4 | GO:0072174 | metanephric tubule formation(GO:0072174) |
0.2 | 3.6 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.2 | 0.2 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.2 | 0.4 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.2 | 1.1 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.2 | 0.4 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.2 | 1.5 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.2 | 0.4 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.2 | 0.2 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) positive regulation of protein localization to synapse(GO:1902474) |
0.2 | 0.7 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.2 | 1.3 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.2 | 1.1 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.2 | 0.4 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.2 | 0.6 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
0.2 | 1.3 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.2 | 1.5 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.2 | 0.4 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.2 | 1.9 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.2 | 0.6 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 0.2 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.2 | 0.6 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.2 | 1.3 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.2 | 0.8 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.2 | 0.6 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.2 | 0.2 | GO:0048369 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.2 | 0.2 | GO:0072718 | response to cisplatin(GO:0072718) |
0.2 | 0.8 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.2 | 0.8 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.2 | 8.3 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.2 | 0.4 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.2 | 0.6 | GO:1903288 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.2 | 0.6 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.2 | 0.2 | GO:0035973 | aggrephagy(GO:0035973) |
0.2 | 16.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.2 | 0.6 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.2 | 0.4 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.2 | 4.6 | GO:0007435 | salivary gland morphogenesis(GO:0007435) |
0.2 | 0.8 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.2 | 1.6 | GO:0060736 | prostate gland growth(GO:0060736) |
0.2 | 1.4 | GO:0060068 | vagina development(GO:0060068) |
0.2 | 5.0 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.2 | 0.2 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.2 | 0.8 | GO:0070842 | aggresome assembly(GO:0070842) |
0.2 | 0.6 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.2 | 0.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.2 | 0.4 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.2 | 5.9 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.2 | 0.6 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.2 | 0.4 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.2 | 0.8 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.2 | 0.6 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.2 | 0.6 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.2 | 0.4 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.2 | 0.6 | GO:0030035 | microspike assembly(GO:0030035) |
0.2 | 0.6 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.2 | 0.6 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 0.7 | GO:0007296 | vitellogenesis(GO:0007296) |
0.2 | 0.6 | GO:0001927 | exocyst assembly(GO:0001927) |
0.2 | 0.7 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 0.4 | GO:1902688 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
0.2 | 0.2 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.2 | 0.9 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.2 | 0.5 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.2 | 1.1 | GO:0070986 | left/right axis specification(GO:0070986) |
0.2 | 0.5 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.2 | 0.4 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.2 | 0.7 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 0.5 | GO:0002860 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.2 | 0.5 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.2 | 0.2 | GO:0072198 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.2 | 0.4 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.2 | 0.9 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.2 | 0.2 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.2 | 0.7 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.2 | 0.9 | GO:0022605 | oogenesis stage(GO:0022605) |
0.2 | 1.2 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.2 | 0.2 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.2 | 4.2 | GO:0007340 | acrosome reaction(GO:0007340) |
0.2 | 0.7 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.2 | 0.5 | GO:0019086 | late viral transcription(GO:0019086) |
0.2 | 0.3 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.2 | 0.7 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.2 | 0.2 | GO:0007412 | axon target recognition(GO:0007412) |
0.2 | 0.7 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.2 | 0.5 | GO:0060482 | lobar bronchus development(GO:0060482) |
0.2 | 1.3 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.2 | 0.5 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.2 | 0.8 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.2 | 1.1 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.2 | 0.8 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.2 | 0.6 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.2 | 0.6 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.2 | 0.3 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.2 | 2.7 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.2 | 0.8 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.2 | 1.0 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.2 | 0.8 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.2 | 2.2 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 0.5 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.2 | 0.9 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.2 | 1.5 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.2 | 1.7 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.2 | 0.5 | GO:0007525 | somatic muscle development(GO:0007525) |
0.2 | 2.9 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.2 | 1.2 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.1 | 0.1 | GO:0009173 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.1 | 0.1 | GO:0006971 | hypotonic response(GO:0006971) |
0.1 | 1.0 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.1 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.1 | 0.4 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.3 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 0.4 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.7 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 1.4 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.3 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.1 | 0.1 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.1 | 0.3 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.1 | 2.0 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 4.6 | GO:0046847 | filopodium assembly(GO:0046847) |
0.1 | 0.1 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.1 | GO:0015846 | polyamine transport(GO:0015846) |
0.1 | 0.1 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 1.2 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.1 | 1.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 2.4 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.1 | 0.9 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.3 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.1 | 0.1 | GO:0046379 | hyaluranon cable assembly(GO:0036118) extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.1 | 0.3 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.1 | 0.4 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.5 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.5 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.4 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.1 | 0.5 | GO:0008038 | neuron recognition(GO:0008038) |
0.1 | 0.8 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.5 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 0.5 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.4 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 0.1 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) |
0.1 | 0.1 | GO:0060166 | olfactory pit development(GO:0060166) |
0.1 | 0.1 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.1 | 0.6 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.4 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.1 | 3.9 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.1 | 0.4 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 1.0 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.1 | 0.2 | GO:0072172 | mesonephric tubule formation(GO:0072172) |
0.1 | 0.2 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.1 | 0.1 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.1 | 0.5 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.1 | 0.2 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.1 | 0.2 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.1 | 0.1 | GO:0002568 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.1 | 1.1 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 2.1 | GO:0003341 | cilium movement(GO:0003341) |
0.1 | 0.2 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.1 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.2 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.1 | 0.1 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.1 | 0.6 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.1 | 0.4 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.1 | 0.4 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.1 | 0.3 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.1 | 0.2 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
0.1 | 1.1 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.1 | 0.6 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.1 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.1 | 0.3 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.3 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.1 | 1.1 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.1 | 0.1 | GO:0060174 | limb bud formation(GO:0060174) |
0.1 | 1.7 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.1 | 0.1 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.1 | 0.4 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.8 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.5 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.1 | 0.3 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.1 | GO:0072126 | positive regulation of glomerular mesangial cell proliferation(GO:0072126) |
0.1 | 0.3 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 0.5 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.3 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.3 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.2 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.6 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.1 | 0.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.3 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.1 | 0.3 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.1 | 0.3 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.1 | 0.3 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.1 | 0.3 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 2.1 | GO:0019228 | neuronal action potential(GO:0019228) |
0.1 | 0.2 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) |
0.1 | 0.4 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.1 | 0.3 | GO:0072203 | cell proliferation involved in metanephros development(GO:0072203) |
0.1 | 0.2 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.1 | 0.4 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.5 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.2 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.1 | 0.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 0.2 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.3 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 0.3 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.1 | 1.7 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 0.4 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.1 | 0.2 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.1 | 0.1 | GO:0030421 | defecation(GO:0030421) |
0.1 | 0.1 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.1 | 0.2 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 0.2 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.1 | 0.2 | GO:0051458 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 0.1 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.1 | 0.2 | GO:0070268 | cornification(GO:0070268) |
0.1 | 0.4 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.1 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.1 | 0.4 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 0.2 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.1 | 1.9 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
0.1 | 1.8 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 0.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.5 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.1 | 0.2 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.1 | GO:0060594 | mammary gland specification(GO:0060594) |
0.1 | 0.3 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.1 | 1.0 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 0.2 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 0.2 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 0.5 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 0.2 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.1 | 0.3 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.1 | 0.1 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.1 | 0.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.1 | 0.3 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.3 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.2 | GO:0034238 | macrophage fusion(GO:0034238) |
0.1 | 0.2 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.1 | 0.8 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.1 | 0.2 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.1 | 0.1 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.1 | 0.1 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.1 | 0.1 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
0.1 | 0.3 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.1 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.1 | 0.2 | GO:0072044 | collecting duct development(GO:0072044) |
0.1 | 0.2 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) positive regulation of sister chromatid cohesion(GO:0045876) |
0.1 | 0.2 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 1.0 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.1 | 0.9 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.1 | 0.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.5 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.1 | GO:0007442 | hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
0.1 | 0.1 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.1 | 0.1 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.1 | 0.1 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.1 | 0.1 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.1 | 0.1 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.1 | 0.2 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.1 | 0.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.1 | GO:0072008 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.1 | 0.4 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.1 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.1 | 0.1 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.1 | 0.7 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.1 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.1 | 0.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.2 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.1 | 0.1 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.1 | 0.1 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.1 | 0.2 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.1 | 0.3 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.2 | GO:0009211 | pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) |
0.1 | 0.1 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.1 | 0.2 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 0.1 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 1.2 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.5 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.1 | 0.1 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.1 | 0.2 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.1 | 0.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.1 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.1 | 0.2 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.1 | 0.3 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 1.2 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.1 | 0.1 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 0.1 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.1 | 0.5 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 0.3 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 1.3 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.1 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.1 | 0.2 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 0.1 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
0.1 | 0.2 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.2 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.2 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 0.2 | GO:0001975 | response to amphetamine(GO:0001975) |
0.1 | 0.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.9 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.1 | 0.1 | GO:0086005 | ventricular cardiac muscle cell action potential(GO:0086005) |
0.1 | 0.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.8 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.1 | 0.3 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 0.1 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.0 | 0.1 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.3 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.3 | GO:0080111 | DNA demethylation(GO:0080111) |
0.0 | 0.0 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.0 | 0.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.3 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.1 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.3 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.0 | 0.5 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.0 | 0.1 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 3.5 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.1 | GO:0032196 | transposition(GO:0032196) |
0.0 | 0.2 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.0 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.0 | GO:0033083 | regulation of immature T cell proliferation(GO:0033083) |
0.0 | 0.1 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.0 | 0.4 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.0 | 0.0 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 0.3 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.5 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.0 | 0.1 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.0 | 0.5 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.2 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.0 | 0.5 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.0 | 0.1 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.0 | 0.3 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.0 | 0.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.1 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.0 | 0.1 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.0 | 0.1 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.3 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.0 | 0.2 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.0 | 1.1 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.3 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.2 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.0 | 0.0 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.0 | 0.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.0 | 0.1 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.0 | 0.3 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.0 | 0.0 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.0 | 0.4 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.0 | 1.3 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.7 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 0.3 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.1 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) |
0.0 | 0.2 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.0 | 0.0 | GO:0051665 | membrane raft localization(GO:0051665) |
0.0 | 0.1 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.0 | 0.2 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.0 | 0.1 | GO:0035627 | ceramide transport(GO:0035627) |
0.0 | 0.0 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.0 | 0.0 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.0 | 0.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.0 | 0.2 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
0.0 | 0.1 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.0 | 0.1 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.0 | 0.0 | GO:0051462 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
0.0 | 0.2 | GO:0090102 | cochlea development(GO:0090102) |
0.0 | 0.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.1 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.0 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.1 | GO:0038001 | paracrine signaling(GO:0038001) |
0.0 | 0.1 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.0 | 0.2 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.0 | 0.1 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.0 | 0.1 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.0 | 0.0 | GO:0010288 | response to lead ion(GO:0010288) |
0.0 | 0.1 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.0 | 0.3 | GO:0070841 | inclusion body assembly(GO:0070841) |
0.0 | 0.1 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.0 | 0.0 | GO:0035425 | autocrine signaling(GO:0035425) |
0.0 | 0.2 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.0 | GO:1900221 | regulation of beta-amyloid clearance(GO:1900221) |
0.0 | 0.1 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.0 | 0.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.1 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.0 | 0.1 | GO:0072567 | chemokine (C-X-C motif) ligand 2 production(GO:0072567) regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000341) |
0.0 | 0.3 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.0 | 0.2 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.0 | 0.1 | GO:0040031 | snRNA modification(GO:0040031) |
0.0 | 0.2 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.0 | 0.0 | GO:0035482 | gastric motility(GO:0035482) |
0.0 | 0.0 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.0 | 0.0 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.1 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) |
0.0 | 0.0 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.0 | 0.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.1 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.0 | 0.1 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 0.2 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.0 | 0.0 | GO:0002767 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.0 | 0.0 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.1 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 0.0 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.0 | 0.1 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.0 | 0.3 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.0 | 0.4 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.1 | GO:1902571 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.0 | 0.1 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.0 | 0.2 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.1 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.0 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.0 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.0 | 0.2 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.0 | 0.0 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.0 | 0.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.0 | 0.1 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.0 | 0.0 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.0 | 0.1 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.0 | 0.0 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.0 | 0.6 | GO:0006400 | tRNA modification(GO:0006400) |
0.0 | 0.1 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.1 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.0 | 0.0 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.0 | 0.0 | GO:0015824 | proline transport(GO:0015824) |
0.0 | 0.0 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.0 | 0.0 | GO:0031296 | B cell costimulation(GO:0031296) |
0.0 | 0.0 | GO:0008355 | olfactory learning(GO:0008355) |
0.0 | 0.1 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.0 | 0.2 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.0 | 0.0 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.0 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 0.0 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.1 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.0 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.0 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.0 | 0.1 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.0 | 0.0 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.0 | 0.0 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.0 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.0 | 0.0 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.0 | 0.0 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.0 | 0.0 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.0 | 0.0 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.0 | 0.0 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.0 | 0.4 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.1 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.0 | 0.0 | GO:0061308 | cardiac neural crest cell development involved in heart development(GO:0061308) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.4 | GO:0097441 | basilar dendrite(GO:0097441) |
1.3 | 7.5 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.0 | 7.2 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.9 | 2.8 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.9 | 2.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.9 | 4.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.7 | 2.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.7 | 5.7 | GO:0043083 | synaptic cleft(GO:0043083) |
0.7 | 7.1 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.7 | 2.0 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.7 | 7.9 | GO:0043194 | axon initial segment(GO:0043194) |
0.7 | 2.6 | GO:0033269 | internode region of axon(GO:0033269) |
0.6 | 3.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.6 | 1.2 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.6 | 6.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.6 | 1.7 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.6 | 4.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.6 | 1.7 | GO:0097427 | microtubule bundle(GO:0097427) |
0.5 | 4.2 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.5 | 1.5 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.5 | 4.2 | GO:0036156 | inner dynein arm(GO:0036156) |
0.5 | 4.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.5 | 2.8 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.4 | 1.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.4 | 1.6 | GO:0044308 | axonal spine(GO:0044308) |
0.4 | 3.9 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.4 | 1.2 | GO:0072534 | perineuronal net(GO:0072534) |
0.4 | 1.1 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.4 | 7.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.4 | 1.5 | GO:1990246 | uniplex complex(GO:1990246) |
0.4 | 1.5 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.4 | 1.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.4 | 3.2 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 1.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 1.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.3 | 8.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.3 | 4.0 | GO:0030673 | axolemma(GO:0030673) |
0.3 | 4.0 | GO:0071565 | nBAF complex(GO:0071565) |
0.3 | 52.1 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.3 | 2.0 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.3 | 0.9 | GO:0033010 | paranodal junction(GO:0033010) |
0.3 | 1.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.3 | 1.1 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.3 | 1.4 | GO:0000235 | astral microtubule(GO:0000235) |
0.3 | 0.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.3 | 0.8 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.3 | 5.7 | GO:0044295 | axonal growth cone(GO:0044295) |
0.3 | 1.3 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 0.5 | GO:0044393 | microspike(GO:0044393) |
0.2 | 0.7 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 8.5 | GO:0034704 | calcium channel complex(GO:0034704) |
0.2 | 0.2 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
0.2 | 1.4 | GO:0097449 | astrocyte projection(GO:0097449) |
0.2 | 0.9 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 0.2 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.2 | 3.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 0.7 | GO:0043511 | inhibin complex(GO:0043511) |
0.2 | 1.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 1.7 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 0.4 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.2 | 0.9 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 3.3 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.2 | 2.0 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.2 | 2.4 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 0.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.2 | 1.0 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 0.8 | GO:1990696 | USH2 complex(GO:1990696) |
0.2 | 0.4 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.2 | 0.9 | GO:0097433 | dense body(GO:0097433) |
0.2 | 2.7 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.2 | 1.4 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 2.1 | GO:0031045 | dense core granule(GO:0031045) |
0.2 | 1.2 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 9.3 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.2 | 0.8 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 0.5 | GO:0032280 | symmetric synapse(GO:0032280) |
0.2 | 1.0 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.2 | 0.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.2 | 0.5 | GO:0055087 | Ski complex(GO:0055087) |
0.2 | 2.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 0.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 0.6 | GO:0070545 | PeBoW complex(GO:0070545) |
0.2 | 16.3 | GO:0060076 | excitatory synapse(GO:0060076) |
0.2 | 0.8 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 0.5 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.1 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.1 | 1.0 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 1.0 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 0.4 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.7 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 1.0 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 0.6 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 5.8 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.4 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.7 | GO:0005688 | U6 snRNP(GO:0005688) |
0.1 | 1.3 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.5 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.1 | 0.6 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 1.4 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 1.2 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.4 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 0.3 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 0.4 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 0.3 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 0.7 | GO:0036157 | axonemal dynein complex(GO:0005858) outer dynein arm(GO:0036157) |
0.1 | 0.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.2 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.1 | 0.1 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.1 | 1.2 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 0.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 0.7 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 4.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 1.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.6 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.1 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 1.0 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.3 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 0.2 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.4 | GO:0097060 | synaptic membrane(GO:0097060) |
0.1 | 0.2 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 0.2 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 0.7 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.0 | 0.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.7 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.8 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 0.3 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.2 | GO:0032584 | growth cone membrane(GO:0032584) |
0.0 | 0.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.0 | GO:0051286 | cell tip(GO:0051286) |
0.0 | 0.5 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 0.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 0.5 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.9 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 1.2 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 5.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.3 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 0.1 | GO:0097386 | glial cell projection(GO:0097386) |
0.0 | 1.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.0 | 0.3 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.0 | 0.1 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.2 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 1.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.4 | GO:0043205 | fibril(GO:0043205) |
0.0 | 0.3 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.1 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.0 | 0.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 0.2 | GO:0070187 | telosome(GO:0070187) |
0.0 | 0.3 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 0.2 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.0 | 0.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.1 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.1 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 0.1 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.0 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.0 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 0.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.2 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 6.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.8 | 5.3 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.2 | 3.6 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.0 | 5.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.0 | 7.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.9 | 2.8 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.9 | 2.8 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.9 | 5.5 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.9 | 2.7 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.8 | 2.5 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.8 | 3.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.8 | 3.4 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.8 | 6.7 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.8 | 4.2 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.8 | 4.0 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.8 | 3.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.7 | 2.2 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.7 | 1.4 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.7 | 2.7 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.7 | 2.7 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.7 | 0.7 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.6 | 7.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.6 | 2.6 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.6 | 1.9 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.6 | 1.8 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.6 | 2.9 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.6 | 1.2 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.6 | 1.7 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.6 | 2.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.6 | 1.7 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.6 | 4.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.5 | 1.6 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.5 | 1.6 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.5 | 1.6 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.5 | 2.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.5 | 4.4 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.5 | 1.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.5 | 4.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.5 | 1.4 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.5 | 0.5 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.5 | 5.9 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.4 | 1.3 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.4 | 1.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.4 | 2.2 | GO:0016151 | nickel cation binding(GO:0016151) |
0.4 | 1.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.4 | 1.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.4 | 2.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.4 | 1.2 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.4 | 2.0 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.4 | 1.6 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.4 | 0.4 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.4 | 1.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.4 | 3.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.4 | 1.5 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.4 | 3.0 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.4 | 1.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.4 | 1.1 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.4 | 0.4 | GO:0055100 | adiponectin binding(GO:0055100) |
0.4 | 4.2 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.4 | 1.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.3 | 0.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.3 | 1.7 | GO:0048495 | Roundabout binding(GO:0048495) |
0.3 | 1.0 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.3 | 0.7 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.3 | 1.3 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.3 | 6.2 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.3 | 3.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.3 | 1.0 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.3 | 1.3 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.3 | 1.3 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.3 | 1.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.3 | 1.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 9.0 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.3 | 1.8 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.3 | 1.2 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.3 | 0.9 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.3 | 8.2 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 0.9 | GO:0035939 | microsatellite binding(GO:0035939) |
0.3 | 3.0 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.3 | 0.9 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.3 | 0.6 | GO:0009374 | biotin binding(GO:0009374) |
0.3 | 1.5 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.3 | 0.8 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.3 | 2.0 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.3 | 8.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.3 | 6.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.3 | 3.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 3.4 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.3 | 0.5 | GO:0097016 | L27 domain binding(GO:0097016) |
0.3 | 3.7 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.3 | 1.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.3 | 0.8 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.3 | 1.0 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.3 | 0.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.3 | 0.8 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.2 | 0.5 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.2 | 1.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 3.1 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.2 | 3.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 0.7 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.2 | 1.8 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.2 | 3.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.2 | 0.7 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.2 | 1.5 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 1.1 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.2 | 2.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 0.6 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 1.5 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 0.6 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.2 | 1.0 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 0.2 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.2 | 0.6 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.2 | 0.8 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.2 | 0.6 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.2 | 0.6 | GO:0019961 | interferon binding(GO:0019961) |
0.2 | 1.0 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.2 | 1.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 3.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 1.0 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.2 | 0.8 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 0.6 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.2 | 1.9 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 0.8 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.2 | 0.6 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 0.2 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.2 | 1.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.2 | 0.6 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.2 | 5.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.2 | 0.7 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.2 | 2.9 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 0.7 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 0.7 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.2 | 3.9 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 1.2 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.2 | 1.5 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.2 | 0.7 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.2 | 0.5 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.2 | 0.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 3.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 0.5 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.2 | 2.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 0.2 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.2 | 0.3 | GO:0043398 | HLH domain binding(GO:0043398) |
0.2 | 3.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 0.8 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 1.0 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 3.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.4 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 0.7 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 4.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.9 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 0.7 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.4 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.1 | 0.4 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.1 | 0.3 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 1.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.4 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 0.5 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 1.5 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.1 | 0.5 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.1 | 2.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 2.9 | GO:0052712 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.1 | 0.5 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.5 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.1 | 0.4 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.6 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 3.5 | GO:0005272 | sodium channel activity(GO:0005272) |
0.1 | 1.6 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 2.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 1.6 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.1 | 2.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.5 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
0.1 | 1.4 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 0.6 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.1 | 0.5 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.4 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.1 | 3.9 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.5 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.4 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.3 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 0.2 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.1 | 0.9 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 0.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 1.0 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 0.3 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.1 | 0.3 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.1 | GO:2001070 | starch binding(GO:2001070) |
0.1 | 2.6 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.4 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.3 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 0.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.1 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.1 | 0.5 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 1.6 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 3.9 | GO:0005267 | potassium channel activity(GO:0005267) |
0.1 | 0.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 2.7 | GO:0034930 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
0.1 | 0.8 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.5 | GO:0019113 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) tocotrienol omega-hydroxylase activity(GO:0052872) thalianol hydroxylase activity(GO:0080014) |
0.1 | 0.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 1.2 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.1 | 0.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.2 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.5 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.1 | 0.4 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.4 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 1.2 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 1.0 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 0.1 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.1 | 0.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.3 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 0.4 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 0.4 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.5 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.2 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.2 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.3 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.1 | 0.3 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 0.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.5 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.1 | 0.3 | GO:0004031 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.1 | 0.3 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.4 | GO:0097617 | annealing helicase activity(GO:0036310) annealing activity(GO:0097617) |
0.1 | 2.0 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 0.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.2 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 0.4 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.0 | 0.2 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.0 | 0.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.1 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.0 | 0.2 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.4 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.0 | 0.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.3 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.1 | GO:0097001 | ceramide binding(GO:0097001) |
0.0 | 0.0 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.0 | 0.0 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.0 | 0.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.0 | 0.2 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 1.0 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.2 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.4 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.1 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.0 | 1.3 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.0 | 0.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 1.0 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.0 | 0.0 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 0.3 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.8 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 1.4 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.1 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.3 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.5 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 0.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.0 | 0.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.7 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.3 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.0 | 0.1 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.0 | 0.1 | GO:0051870 | methotrexate binding(GO:0051870) |
0.0 | 0.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.0 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.1 | GO:0044682 | GTP cyclohydrolase activity(GO:0003933) N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.0 | 1.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.0 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 0.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.1 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.1 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 0.0 | GO:0003896 | DNA primase activity(GO:0003896) |
0.0 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.0 | GO:0034559 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.0 | 0.1 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 0.8 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 1.3 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 0.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.0 | 0.0 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 6.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.4 | 0.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.3 | 6.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.3 | 2.4 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 4.7 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 0.7 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 0.9 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 8.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.2 | 3.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 5.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 7.0 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 0.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.9 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 2.9 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 1.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 2.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 3.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.2 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 0.8 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 2.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 2.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 1.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 0.2 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 1.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 0.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 1.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.2 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 2.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.4 | NABA COLLAGENS | Genes encoding collagen proteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 2.6 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.6 | 8.5 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.5 | 1.6 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.4 | 4.0 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.4 | 4.9 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.4 | 4.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.4 | 6.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.4 | 1.7 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.4 | 4.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.4 | 3.6 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.4 | 12.6 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.4 | 7.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.3 | 8.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 2.6 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.3 | 4.1 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.3 | 2.9 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.3 | 0.6 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.3 | 11.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.3 | 0.8 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.3 | 3.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.3 | 4.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 3.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 0.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 5.0 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 0.2 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.2 | 0.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 2.8 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 3.8 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.2 | 2.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.2 | 2.1 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.2 | 0.7 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.2 | 0.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.2 | 0.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 1.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 0.1 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 2.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 2.1 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 1.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.8 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 1.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 2.0 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.4 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.1 | 3.5 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 1.0 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 1.1 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 0.8 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 3.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 2.0 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 1.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 0.1 | REACTOME TRAF6 MEDIATED INDUCTION OF NFKB AND MAP KINASES UPON TLR7 8 OR 9 ACTIVATION | Genes involved in TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation |
0.1 | 2.3 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 3.2 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 1.0 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 0.7 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 1.4 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 0.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 1.0 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 1.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 1.0 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.1 | 2.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 2.2 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.1 | 1.2 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 0.9 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.0 | 0.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.3 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 0.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.2 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.2 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.3 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.1 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.1 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |